chr21-46145457-G-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_206965.2(FTCD):c.1220C>A(p.Thr407Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00133 in 1,560,728 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_206965.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FTCD | NM_206965.2 | c.1220C>A | p.Thr407Lys | missense_variant | 10/14 | ENST00000397746.8 | NP_996848.1 | |
FTCD | NM_001320412.2 | c.1220C>A | p.Thr407Lys | missense_variant | 10/15 | NP_001307341.1 | ||
FTCD | NM_006657.3 | c.1220C>A | p.Thr407Lys | missense_variant | 10/15 | NP_006648.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FTCD | ENST00000397746.8 | c.1220C>A | p.Thr407Lys | missense_variant | 10/14 | 1 | NM_206965.2 | ENSP00000380854.3 |
Frequencies
GnomAD3 genomes AF: 0.00110 AC: 167AN: 152160Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.00200 AC: 337AN: 168516Hom.: 8 AF XY: 0.00190 AC XY: 172AN XY: 90582
GnomAD4 exome AF: 0.00136 AC: 1910AN: 1408450Hom.: 16 Cov.: 32 AF XY: 0.00135 AC XY: 943AN XY: 696084
GnomAD4 genome AF: 0.00110 AC: 167AN: 152278Hom.: 1 Cov.: 31 AF XY: 0.00112 AC XY: 83AN XY: 74434
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | FTCD: BP4 - |
Glutamate formiminotransferase deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 06, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at